MedPath

Efficacy of AlbenDazole to inDuce mUcosal healing in Patients with Crohn's disease on anti-TNF monotherapy: ADD UP

Recruiting
Conditions
Crohn's disease
Registration Number
NL-OMON29213
Lead Sponsor
Amsterdam University Medical Center (location meibergdreef)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
110
Inclusion Criteria

•Patients ≥18 years and ≤65 years

•Diagnosis of CD, based on endoscopy and histopathologic examination of mucosal biopsies

Exclusion Criteria

•Ulcerative colitis or indeterminate colitis

•Current malignancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
•Proportion of patients with absence of ulcers on centrally read endoscopies after 12 weeks of albendazole and anti-TNF combination treatment compared to placebo
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath